LYOPHILIZED PRODUCT MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2021 to 2028)

Lyophilization or freeze drying is the process in which the water content in the drug sample is frozen, followed by its removal from the sample. In the process of lyophilization, the frozen water content changes directly from solid to vapor without passing through a liquid phase. The process includes three steps: freezing, primary drying (sublimation), and secondary drying (desorption). Pharmaceutical products that undergo lyophilization process include bulk pharmaceutical/biopharmaceutical ingredient, protein, collagen, peptide, oligonucleotide, enzymes, and mAbs (Monoclonal Antibody)

Market Dynamics

Key market players are focusing on increasing product launches and approvals, which is expected drive the growth of the market over forecast period. For instance, in May 2019, Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., received the U.S. Food and Drug Administration (FDA) approval for a new dosage form (50 mg) and two new indications for pembrolizumab available as a lyophilized powder (Keytruda): Non–small-cell Lung Cancer (NSCLC) and Renal Cell Carcinoma (RCC). Additionally, in December 2020, Novartis AG, a global healthcare company, announced that the European Commission (EC) approved Xolair (omalizumab) as an add-on therapy with intranasal corticosteroids (INC) for the treatment of adults (18 years and above) with severe chronic rhinosinusitis with nasal polyps (CRSwNP), where therapy only with INC does not provide adequate disease control.

Key features of the study:

• This report provides an in-depth analysis of the global lyophilized product market, market size (US$ Bn), and compound annual growth rate (CAGR%) for the forecast period (2021–2028), considering 2020 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global lyophilized product market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Sanofi, Merck & Co., Inc., Fresenius Kabi AG, Ciron Drugs & Pharmaceuticals Pvt. Ltd., Glaxosmithkline Plc, Mylan NV., Pfizer, Inc., Amneal Pharmaceuticals LLC, Otsuka Holdings Co. Ltd., BTG PLC, Bristol-Myers Squibb Company, Novartis AG, Takeda Pharmaceutical Company Limited, Biogen Inc., Dr. Reddy's Laboratories Ltd., Zydus Cadila, AbbVie Inc., Cipla Inc., Johnson & Johnson Services, Inc., Affy Pharma Private Limited, Jubilant Pharmova Limited, and Biocon
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global lyophilized product market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global lyophilized product market

Detailed Segmentation:

• Global Lyophilized Product Market, By Drug Class:
  • Anti-infective
  • Antineoplastic
  • Diuretics
  • Proton pump inhibitor
  • Anesthetic
  • Anticoagulant
  • NSAIDs
  • Others
• Global Lyophilized Product Market, By Indication:
  • Infectious Disease
  • Autoimmune Diseases
  • Gastrointestinal Diseases
  • Cancer
  • Others
• Global Lyophilized Product Market, Packaging Type:
  • Vial
  • Syringes
  • Cartridge
• Global Lyophilized Product Market, By Region:
  • North America
    • By Country
      • U.S.
      • Canada
  • Latin America
    • By Country
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • By Country
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • By Country
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • By Country
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • By Region/Country
      • South Africa
      • Central Africa
      • North Africa
• Company Profiles
  • Sanofi*
    • Company Highlights
    • Product Types Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Merck & Co., Inc.
  • Fresenius Kabi AG
  • Ciron Drugs & Pharmaceuticals Pvt. Ltd
  • Glaxosmithkline Plc
  • Mylan NV.
  • Pfizer, Inc.
  • Amneal Pharmaceuticals LLC
  • Otsuka Holdings Co. Ltd.
  • BTG PLC
  • Bristol-Myers Squibb Company
  • Novartis AG
  • Takeda Pharmaceutical Company Limited
  • Biogen Inc.
  • Dr. Reddy's Laboratories Ltd.
  • Zydus Cadila
  • AbbVie Inc.
  • Cipla Inc.
  • Johnson & Johnson Services, Inc.
  • Affy Pharma Private Limited
  • Jubilant Pharmova Limited
  • Biocon

“*” marked represents similar segmentation in other categories in the respective section.